Novartis presents results from first global registration trial of CTL019 in pediatric and young adult patients with r/r B-ALL

Novartis presents results from first global registration trial of CTL019 in pediatric and young adult patients with r/r B-ALL

Dec 03, 2016

Source URL: https://qa1.novartis.us/us-en/news/media-releases/novartis-presents-results-from-first-global-registration-trial-ctl019-pediatric-and-young-adult-patients-rr-b-all-0

List of links present in page
  1. https://qa1.novartis.us/us-en/us-en/news/media-releases/novartis-presents-results-from-first-global-registration-trial-ctl019-pediatric-and-young-adult-patients-rr-b-all-0